Globe Newswire

Form 8.3 - [LOK'N STORE GROUP PLC - 12 06 2024] - (CGWL) Jun 13, 2024 08:17AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)

Steakholder Foods® Continues Building Strategic Partnerships, Unveils New Product Offering in Collaboration with Sherry Herring Jun 13, 2024 08:15AM   Eat meat sustainably.Be a Steakholder

New Vegan Fish Salads Developed by Steakholder Foods with Proprietary SHFISH™ Premix Blends to be Introduced by Sherry Herring

Momentum Builds as Collaborations Expand Steakholder Foods’ Geographic Footprint, Customer Base and Product Lineup

Rehovot, Israel, June 13, 2024 (GLOBE NEWSWIRE) -- Steakholder Foods Ltd. (Nasdaq: STKH) (the “Company”), a leading innovator in alternative proteins and 3D printing... (continue reading...)

Blink Charging Achieves “In Process” FedRAMP® Status to Provide Cloud-Based EV Charging Solutions Across U.S. Government Jun 13, 2024 08:15AM

Once fully accredited, Blink’s EV charging network will be available to government agencies.

Bowie, Md., June 13, 2024 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, today announced it has achieved the “In Process” designation granted by the Federal Risk and Authorization Management Program (FedRAMP®) for its EV... (continue reading...)

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236 Jun 13, 2024 08:15AM

Company anticipates near term filing of Investigational New Drug Application to FDA

SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announced it successfully executed pre-IND manufacturing activities for its lead therapeutic, CER-1236. The completion of... (continue reading...)

Form 8.3 - [KEYWORDS STUDIOS PLC - 12 06 2024] - (CGWL) Jun 13, 2024 08:12AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the... (continue reading...)